Integrins are a family of transmembrane glycoproteins that can interact wit
h components of the extracellular matrix. The alpha4 beta1 and alpha4 beta7
integrins are heterodimeric leukocyte cell surface molecules critical to t
heir cell and matrix adhesive interactions. Evidence for a central role for
the alpha4 integrins in leukocyte pathophysiology in the lung is well docu
mented. In this study, we tested the hypothesis that neutralizing antibody
for integrin alpha4 (PS2) may reduce bleomycin (BL)-induced lung fibrosis i
n vivo. Male C57BL/6 mice were injected intratracheally with saline (SA) or
BL (0.08 U/mouse) followed by intraperitoneal injection of SA, isotype con
trol antibody (1E6), or PS2 (100 mug) three times a week. Twenty-one days a
fter the intratracheal instillation mice were killed for bronchoalveolar la
vage (BAL), biochemical, histopathological, and immunohistological analyses
. Treatment with PS2 significantly reduced BL-induced increases in lung lip
id peroxidation and hydroxyproline content. Lung histopathology also showed
reduced fibrotic lesions in the BL-treated lungs by treatment with PS2. BL
-treated mouse lungs also showed induction of cells with the myofibroblast
phenotype, as indicated by the increased expression of alpha -smooth muscle
actin (alpha SMA), whereas treatment with PS2 minimized the BL-induced alp
ha SMA expression. Furthermore, treatment with PS2 reduced the BL-induced i
ncrease in the BAL total cell number, and attenuated the BL-induced increas
e in the BAL protein level. It is concluded that integrin alpha4 may play a
n important role in BL-induced pulmonary fibrosis, and the use of anti-alph
a4 antibody offers therapeutic antifibrotic potential in vivo. BIOCHEM I PH
ARMACOL 60;12:1949 -1958, 2000. (C) 2000 Elsevier Science Inc.